7/102 sources · 2 publishersUpdated Oct 13, 15:48 UTC
Pinnacle Food announces first bench‑scale methanol‑free fermentation of recombinant human lactoferrin
Pinnacle Food disclosed that its subsidiary completed a bench‑scale test using a methanol‑free Pichia fermentation method to produce recombinant human lactoferrin. The result moves the program from laboratory proof‑of‑concept toward commercial‑scale manufacturing. The announcement triggered a sharp rise in the company’s share price.
Why it matters
The company says the breakthrough could enable cost‑effective production of a high‑value protein used in infant nutrition and supplements, opening a new revenue stream. The stock’s rapid appreciation reflects investor expectations of future commercial sales.
Key facts
- 1Pinnacle Food achieved its first bench‑scale fermentation of recombinant human lactoferrin using a methanol‑free Pichia method. investing.com
- 2The breakthrough was announced by the subsidiary Pinnacle Food AgTech HK Limited. seekingalpha.com
Open questions
- Material 1 reports a 186.6% pre‑market price increase to $7.48, while material 2 reports a 93% intraday increase; both describe the same percentage gain metric but differ in magnitude.
Summary written by AlphAI AI Desk from 2 of 2 sources. Not investment advice. Figures are as stated by the linked sources.